Calyx RIM publishing module relied on for critical submissions of coronavirus vaccine trial data to global regulatory bodies NOTTINGHAM, England, June 10, 2021 /PRNewswire/ Calyx, the
Calyx IRT Reaches Milestone in Supporting 500 Global Regulatory Approvals
Industry-proven randomization and trial supply management (RTSM) solution ensures reliability of drug supply and patient safety.
News provided by
Share this article
Share this article
NOTTINGHAM, United Kingdom, April 21, 2021 /PRNewswire/ Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced its Interactive Response Technology (IRT) solution has reached a significant milestone. Global regulators have approved 500 medical treatments which included the use of Calyx IRT for randomization and trial supply management (RTSM) during clinical development.
Gavin Nichols, CEO of Calyx is honored that so many global clinical researchers rely on Calyx IRT to remove RTSM risks, which became even more critical when sponsors and CROs turned to Calyx to come up with novel solutions for delivering study medication d
Calyx Offers Scientific Consulting to Optimize Clinical Development
Highly tenured scientific, medical, and regulatory experts ensure scientific integrity and regulatory compliance of clinical trial imaging
News provided by
Share this article
Share this article
NOTTINGHAM, United Kingdom, Feb. 25, 2021 /PRNewswire/ Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced a scientific consulting program aimed at optimizing imaging processes and outcomes to accelerate the clinical development of new medical treatments.
Through Calyx Scientific Consulting, biopharmaceutical researchers can extend the deep and diverse experience of Calyx s highly tenured medical, scientific, and regulatory experts to their own clinical development teams.
Calyx Launches CRO Partnership Program
ACTIVATE partnership program drives customer value for participating CROs
News provided by
Share this article
Share this article
NOTTINGHAM, United Kingdom, Jan. 25, 2021 /PRNewswire/ Calyx, the eClinical solutions and services provider most relied on for solving complex data challenges in clinical research, today announced a valuable new partnership program for Clinical Research Organizations (CROs).
Calyx CCO, John Blakeley, outlines how CROs can better meet their clients’ needs through the ACTIVATE Solutions for CRO Partners program
CROs accelerate study execution, increase efficiencies, and improve study quality through Calyx s partnership program
The program, ACTIVATE Solutions for CRO Partners, is designed to provide close alignment between Calyx and its CRO partners. By participating in the ACTIVATE program, CROs can meet the needs of their many different clients and help accelerate trial execution and data collection,
Imbuing conventional dress codes with progressive values is, unsurprisingly, a big theme this men’s season. The social unrest of 2020 has made houses from Louis Vuitton to Hermès think beyond the surface of change. Now, fashion wants to change the meaning of its own codes entirely, and promote freedom of identity. As a drop in the new bloodline of designers flowing through the veins of the industry, Matthew Williams speaks that language. His co-ed collection for 1017 Alyx 9SM (say it ten times fast) continued his free game of mixing and matching the codes of traditional wardrobes through the fabrication-centric approach that defines his work.